Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerShanu Modi, David Cameron, Naoto T. Ueno et al.|New England Journal of Medicine|2022Cited by 2.5k
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinomaMasatoshi Kudo, Kiwamu Okita, Kazuho Imanaka et al.|European Journal of Cancer|2011Cited by 573
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancerTakayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav et al.|Nature Communications|2023Cited by 159
Autologous stem-cell transplantation restores the functional properties of CD14+CD16+ monocytes in patients with myeloma and lymphomaFarshid Dayyani, Gerold Meinhardt|Journal of Leukocyte Biology|2003Cited by 18